Journal of Cancer Science and Research is an open access publication and peer reviewed journal for original submissions, reviews, surgeons reports and treatment of cancer etc.
Cancer Studies and Research Journal SciDocPublishersScidoc Publishers
International Journal of Cancer Studies & Research (IJCR) ISSN:2167-9118 is a comprehensive, peer reviewed journal devoted to cancer studies and research. IJCR, published by SciDocPublishers is an open access journal that includes high quality papers, which covers all major areas of Cancer and its related fields. SciDocPubishers with its Open Access publication model spreads all the day-to-day developments and research to readers around the world.
IJCR intends to provide researchers in the field of Cancer, with the latest developments which can save millions of lives worldwide. Identifying and protecting new cancer discoveries could form the basis of new diagnostics, therapeutics or changing technologies from the research of leading international researchers.
For more details: http://scidoc.org/cancer-studies-and-research.php
Journal of Cancer Science and Research is an open access publication and peer reviewed journal for original submissions, reviews, surgeons reports and treatment of cancer etc.
Cancer Studies and Research Journal SciDocPublishersScidoc Publishers
International Journal of Cancer Studies & Research (IJCR) ISSN:2167-9118 is a comprehensive, peer reviewed journal devoted to cancer studies and research. IJCR, published by SciDocPublishers is an open access journal that includes high quality papers, which covers all major areas of Cancer and its related fields. SciDocPubishers with its Open Access publication model spreads all the day-to-day developments and research to readers around the world.
IJCR intends to provide researchers in the field of Cancer, with the latest developments which can save millions of lives worldwide. Identifying and protecting new cancer discoveries could form the basis of new diagnostics, therapeutics or changing technologies from the research of leading international researchers.
For more details: http://scidoc.org/cancer-studies-and-research.php
Dr. Talita Resende - Organoids as an invitro model for enteric diseasesJohn Blue
Organoids as an invitro model for enteric diseases - Dr. Talita Resende, from the 2018 Allen D. Leman Swine Conference, September 15-18, 2018, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2018-leman-swine-conference-material
Can SAR Database: An Overview on System, Role and Applicationinventionjournals
: The intention of this paper is to provide an technical overview on the largest cancer database, the canSAR database system. This overview includes the basic definitions and terminology, findings and advancements infield of cancer research through canSAR database, with basic system architecture, design, data source, processing pipelines, screening tests and structure activity relationship of system.
Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer that begins in basal cells of the skin is called basal cell carcinoma.
Cancer types can be grouped into broader categories. The main categories of cancer include:
-- Carcinoma - cancer that begins in the skin or in tissues that line or cover internal organs.
-- Sarcoma - cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue.
-- Leukemia - cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of abnormal blood cells to be produced and enter the blood.
-- Lymphoma and myeloma - cancers that begin in the cells of the immune system.
-- Central nervous system cancers - cancers that begin in the tissues of the brain and spinal cord.
(For definitions of other cancer-related terms, see NCI's Dictionary of Cancer Terms.)
Origins of CancerAll cancers begin in cells, the body's basic unit of life. To understand cancer, it's helpful to know what happens when normal cells become cancer cells.
The body is made up of many types of cells. These cells grow and divide in a controlled way to produce more cells as they are needed to keep the body healthy. When cells become old or damaged, they die and are replaced with new cells.
However, sometimes this orderly process goes wrong. The genetic material (DNA) of a cell can become damaged or changed, producing mutations that affect normal cell growth and division. When this happens, cells do not die when they should and new cells form when the body does not need them. The extra cells may form a mass of tissue called a tumor.
(Image from Understanding Cancer Series: Cancer.)
Not all tumors are cancerous; tumors can be benign or malignant.
Benign tumors aren't cancerous. They can often be removed, and, in most cases, they do not come back. Cells in benign tumors do not spread to other parts of the body.
Malignant tumors are cancerous. Cells in these tumors can invade nearby tissues and spread to other parts of the body. The spread of cancer from one part of the body to another is called metastasis.
Some cancers do not form tumors. For example, leukemia is a cancer of the bone marrow and blood.
Cancer StatisticsA report from the nation's leading cancer organizations shows that rates of death in the United States from all cancers for men and women continued to fall between 2004 and 2008, the most recent reporting period available. (Read more about the Annual Report.)
Estimated new cases and deaths from cancer in the United States in 2012:
New cases: 1,638,
OMICS Publishing Group, Journal of Carcinogenesis & Mutagenesis features the critical reviews focused on topics of significant interest to specialists in cancer biology and mutation research, scope of the journal reflects the rapid advances in the field of mutation research and latest developments in gene therapy for cancer.
A summary of the research work of Jean-Claude Bradley at Drexel University September 2007. A few slides on the CombiUgi project and malaria then some screenshots of the Open Notebook Science project UsefulChem.
Are we Still Missing the Target in Trying to Prevent and Treat Human Cancers?...CrimsonpublishersCancer
Solving the problem of preventing or treating cancers is still a major problem. While much is known about those multi-disciplinary contributors to the initiation, promotion and progression phases of human cancers, major hurdles to efficacious prevention and treatment involve, while recognizing that there are many known factors that can influence human carcinogenesis, little integration of this knowledge has been used. This brief “Opinion” paper hypothesizes that, by recognizing the multi-stage, multi-mechanism process of carcinogenesis, the roles of organ-specific adult stem cells as the “targets for two types of “cancer stem cells”, and new strategies for nutritional /dietary intervention, could help in the prevention of early susceptibility for cancers later in life, as well as for treatment for the two very different “cancer stem cells”. “In this light, a new perspective for therapeutic intervention by directing differentiation and restoring communications between cancer cells is certainly relevant, and the example of gap junctions is illuminating” .
Richard Sullivan presenting on eCancerHub at the 'Cancer on the Internet' session at the European Multidisciplinary Cancer Congress in Stockholm, Sept 2011
Cell within a tumor that possess the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor”.
“CSC can thus only be defined experimentally by their ability to recapitulate the generation of a continuously growing tumor”.
Building a massive biomedical knowledge graph with citizen scienceBenjamin Good
The life sciences are faced with a rapidly growing array of technologies for measuring the molecular states of living things. From sequencing platforms that can assemble the complete genome sequence of a complex organism involving billions of nucleotides in a few days to imaging systems that can just as rapidly churn out millions of snapshots of cells, biology is truly faced with a data deluge. To translate this information into new knowledge that can guide the search for new medicines, biomedical researchers increasingly need to build on the existing knowledge of the broad community. Prior knowledge can help guide searches through the masses of new data. Unfortunately, most biomedical knowledge is represented solely in the text of journal articles. Given that more than a million such articles are published every year, the challenge of using this knowledge effectively is substantial. Ideally, knowledge such as the interrelations between genes, drugs and diseases would be represented in a knowledge graph that enabled queries like: “show me all the genes related to this disease or related to any drugs used to treat this disease”. Systems exist that attempt to extract this information automatically from text, but the quality of their output remains far below what can be obtained by human readers. We are developing a new platform that taps the language comprehension abilities of citizen scientists to help excavate a queryable knowledge graph from the biomedical literature. In proof-of-concept experiments, we have demonstrated that lay-people are capable of extracting meaningful information from complex biological text. The information extracted using this community intelligence framework can surpass the efforts of individual experts in quality while also offering the potential to achieve massive scale. In this presentation we will describe the results of early experiments and introduce our prototype citizen science platform: http://mark2cure.org.
An overview of the John Theurer Cancer Center at Hackensack University Medical Center - a top-50 U.S. News & World Report Best Hospitals for Cancer – the only cancer center in New Jersey with this prestigious designation.
To request printed copies of this brochure, please contact aleahing@p4strategy.com.
Dr. Talita Resende - Organoids as an invitro model for enteric diseasesJohn Blue
Organoids as an invitro model for enteric diseases - Dr. Talita Resende, from the 2018 Allen D. Leman Swine Conference, September 15-18, 2018, St. Paul, Minnesota, USA.
More presentations at http://www.swinecast.com/2018-leman-swine-conference-material
Can SAR Database: An Overview on System, Role and Applicationinventionjournals
: The intention of this paper is to provide an technical overview on the largest cancer database, the canSAR database system. This overview includes the basic definitions and terminology, findings and advancements infield of cancer research through canSAR database, with basic system architecture, design, data source, processing pipelines, screening tests and structure activity relationship of system.
Cancer is a term used for diseases in which abnormal cells divide without control and are able to invade other tissues. Cancer cells can spread to other parts of the body through the blood and lymph systems.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer that begins in basal cells of the skin is called basal cell carcinoma.
Cancer types can be grouped into broader categories. The main categories of cancer include:
-- Carcinoma - cancer that begins in the skin or in tissues that line or cover internal organs.
-- Sarcoma - cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue.
-- Leukemia - cancer that starts in blood-forming tissue such as the bone marrow and causes large numbers of abnormal blood cells to be produced and enter the blood.
-- Lymphoma and myeloma - cancers that begin in the cells of the immune system.
-- Central nervous system cancers - cancers that begin in the tissues of the brain and spinal cord.
(For definitions of other cancer-related terms, see NCI's Dictionary of Cancer Terms.)
Origins of CancerAll cancers begin in cells, the body's basic unit of life. To understand cancer, it's helpful to know what happens when normal cells become cancer cells.
The body is made up of many types of cells. These cells grow and divide in a controlled way to produce more cells as they are needed to keep the body healthy. When cells become old or damaged, they die and are replaced with new cells.
However, sometimes this orderly process goes wrong. The genetic material (DNA) of a cell can become damaged or changed, producing mutations that affect normal cell growth and division. When this happens, cells do not die when they should and new cells form when the body does not need them. The extra cells may form a mass of tissue called a tumor.
(Image from Understanding Cancer Series: Cancer.)
Not all tumors are cancerous; tumors can be benign or malignant.
Benign tumors aren't cancerous. They can often be removed, and, in most cases, they do not come back. Cells in benign tumors do not spread to other parts of the body.
Malignant tumors are cancerous. Cells in these tumors can invade nearby tissues and spread to other parts of the body. The spread of cancer from one part of the body to another is called metastasis.
Some cancers do not form tumors. For example, leukemia is a cancer of the bone marrow and blood.
Cancer StatisticsA report from the nation's leading cancer organizations shows that rates of death in the United States from all cancers for men and women continued to fall between 2004 and 2008, the most recent reporting period available. (Read more about the Annual Report.)
Estimated new cases and deaths from cancer in the United States in 2012:
New cases: 1,638,
OMICS Publishing Group, Journal of Carcinogenesis & Mutagenesis features the critical reviews focused on topics of significant interest to specialists in cancer biology and mutation research, scope of the journal reflects the rapid advances in the field of mutation research and latest developments in gene therapy for cancer.
A summary of the research work of Jean-Claude Bradley at Drexel University September 2007. A few slides on the CombiUgi project and malaria then some screenshots of the Open Notebook Science project UsefulChem.
Are we Still Missing the Target in Trying to Prevent and Treat Human Cancers?...CrimsonpublishersCancer
Solving the problem of preventing or treating cancers is still a major problem. While much is known about those multi-disciplinary contributors to the initiation, promotion and progression phases of human cancers, major hurdles to efficacious prevention and treatment involve, while recognizing that there are many known factors that can influence human carcinogenesis, little integration of this knowledge has been used. This brief “Opinion” paper hypothesizes that, by recognizing the multi-stage, multi-mechanism process of carcinogenesis, the roles of organ-specific adult stem cells as the “targets for two types of “cancer stem cells”, and new strategies for nutritional /dietary intervention, could help in the prevention of early susceptibility for cancers later in life, as well as for treatment for the two very different “cancer stem cells”. “In this light, a new perspective for therapeutic intervention by directing differentiation and restoring communications between cancer cells is certainly relevant, and the example of gap junctions is illuminating” .
Richard Sullivan presenting on eCancerHub at the 'Cancer on the Internet' session at the European Multidisciplinary Cancer Congress in Stockholm, Sept 2011
Cell within a tumor that possess the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor”.
“CSC can thus only be defined experimentally by their ability to recapitulate the generation of a continuously growing tumor”.
Building a massive biomedical knowledge graph with citizen scienceBenjamin Good
The life sciences are faced with a rapidly growing array of technologies for measuring the molecular states of living things. From sequencing platforms that can assemble the complete genome sequence of a complex organism involving billions of nucleotides in a few days to imaging systems that can just as rapidly churn out millions of snapshots of cells, biology is truly faced with a data deluge. To translate this information into new knowledge that can guide the search for new medicines, biomedical researchers increasingly need to build on the existing knowledge of the broad community. Prior knowledge can help guide searches through the masses of new data. Unfortunately, most biomedical knowledge is represented solely in the text of journal articles. Given that more than a million such articles are published every year, the challenge of using this knowledge effectively is substantial. Ideally, knowledge such as the interrelations between genes, drugs and diseases would be represented in a knowledge graph that enabled queries like: “show me all the genes related to this disease or related to any drugs used to treat this disease”. Systems exist that attempt to extract this information automatically from text, but the quality of their output remains far below what can be obtained by human readers. We are developing a new platform that taps the language comprehension abilities of citizen scientists to help excavate a queryable knowledge graph from the biomedical literature. In proof-of-concept experiments, we have demonstrated that lay-people are capable of extracting meaningful information from complex biological text. The information extracted using this community intelligence framework can surpass the efforts of individual experts in quality while also offering the potential to achieve massive scale. In this presentation we will describe the results of early experiments and introduce our prototype citizen science platform: http://mark2cure.org.
An overview of the John Theurer Cancer Center at Hackensack University Medical Center - a top-50 U.S. News & World Report Best Hospitals for Cancer – the only cancer center in New Jersey with this prestigious designation.
To request printed copies of this brochure, please contact aleahing@p4strategy.com.
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body.
## To understand how cancer develops and progresses, researchers first need to investigate the biological differences between normal cells and cancer cells. This work focuses on the mechanisms that underlie fundamental processes such as cell growth, the transformation of normal cells to cancer cells, and the spread, or metastasis, of cancer cells.
ZOOM: Pancreatic Cancer
• NEWS: Publication by Juan IOVANNA
• IMODI around the world: Meet the experts!
• FOCUS: From the bench to the bedside, INSERM U1068
• WEB-CATALOGUE: 20 in-vitro cell models available
Define Structure of Cell
Define cancer
Explain Lung Cancer
Explain Epidemiology or statistics of Lung Cancer
Signs and Symptoms of Lung Cancer
risk factors of Lung cancer
methods used to diagnose lung cancer
treatment given to lung cancer
preventive measures of Lung Cancer
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Salas, V. (2024) "John of St. Thomas (Poinsot) on the Science of Sacred Theol...Studia Poinsotiana
I Introduction
II Subalternation and Theology
III Theology and Dogmatic Declarations
IV The Mixed Principles of Theology
V Virtual Revelation: The Unity of Theology
VI Theology as a Natural Science
VII Theology’s Certitude
VIII Conclusion
Notes
Bibliography
All the contents are fully attributable to the author, Doctor Victor Salas. Should you wish to get this text republished, get in touch with the author or the editorial committee of the Studia Poinsotiana. Insofar as possible, we will be happy to broker your contact.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Toxic effects of heavy metals : Lead and Arsenicsanjana502982
Heavy metals are naturally occuring metallic chemical elements that have relatively high density, and are toxic at even low concentrations. All toxic metals are termed as heavy metals irrespective of their atomic mass and density, eg. arsenic, lead, mercury, cadmium, thallium, chromium, etc.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Nucleic Acid-its structural and functional complexity.
Hyperplasia of Cancer
1. Hyperplasia of Cancer
http://www.scholoxy.org/journals/cancer.php
By Scholoxy Publications
www.scholoxy.org
2. Scholoxy Publications
Scholoxy Publications is an Open Access Journal
Publisher. Scholoxy Publications provide expertise
and high quality papers for a wide range of subject
areas, including basic research of cells and proteins,
drug discovery research as well as upcoming new
advances in science and technology.
3. Scope of the Journal
Hyperplasia of Cancer Journal from the Scholoxy
aims in publishing high quality scientific content
papers in open access.
The Scope of the Hyperplasia of Cancer Journal
covers multidisciplinary aspect of cancer,
emphasizing cancer biology, oncogenesis,
carcinogenesis, infectious causes of cancer, tumor
immunology, antioxidants, and potential
therapeutics in curing cancer.
4. Subject Areas
Types of Cancers :
1. Carcinoma (Adenocarcinoma and Squamous cell carcinoma)
2. Sarcoma (Soft tissue cancers, Primary bone cancers and Gastro-intestinal
stromal tumours)
3. BN Myeloma ( Plasma cell cancers- Multiple myeloma)
4. Leukemia (Lymphoblastic leukemia, Myelogenous and
Polycythemia
5. Lymphoma (Hodgkin lymphoma and Non-Hodgkin lymphoma)
6. Mixed Types (Adenosquamous, Carcinosarcoma, Teratocarcinoma)
5. Subject Areas
Cancer Biology :
1. Signal Transduction
2. Apoptosis
3. Genomic Instability
4. Growth Factors
5. Cell and Molecular Biology
6. Mutation
7. DNA Repair
8. Genetics
Oncology :
1. Experimental Oncology
2. Clinical Oncology
3. Translational Oncology
4. Cancer Epidemiology
5. Gynecologic Oncology
6. Neuro-Oncology
7. Radiation Oncology
8. Pediatric Oncology
6. Editorial Board
The Editorial Board of the Journal has been built with
eminent persons all over the world.
Please visit :
http://www.scholoxy.org/journals/cancer/editorial-board.
php
7. Authors Benefits
•High Visibility and High Availability
•Open Access
•Frequency of citation
•Ease of Access, Global Articles(DOI to the articles)
•Rapid Review Process
8. Preparation of Manuscript
Please find the link for the instructions for the authors to
prepare the Manuscript.
http://www.scholoxy.org/journals/cancer/authors.php
9. Submit Manuscript
Submit your manuscript online
http://www.scholoxy.org/journals/cancer/submit-manuscript.
php
10. Contact Information
Contact us @
contactus@scholoxy.org
Editorial Office of the Journal @
editorialcancer@scholoxy.org
Visit Us
www.scholoxy.org